Clinical Outcomes of Second-Generation Limus-Eluting Stents Compared to Paclitaxel-Eluting Stents for Acute Myocardial Infarction With Cardiogenic Shock

PLoS ONE - United States
doi 10.1371/journal.pone.0214417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2009English

Initial Pathological Responses of Second-Generation Everolimus-Eluting Stents Implantation in Japanese Coronary Arteries: Comparison With First-Generation Sirolimus-Eluting Stents

Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Is Diabetes the Achilles' Heel of Limus-Eluting Stents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Comparison of the First- And Second-Generation Limus-Eluting Stents for Bifurcation Lesions From a Korean Multicenter Registry

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Long-Term Comparison of Everolimus-Eluting Stents With Sirolimus- And Paclitaxel-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Grafts

EuroIntervention
MedicineCardiovascular MedicineCardiology
2014English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Long-Term Outcome of Drug-Eluting vs. Bare-Metal Stents in Patients With Acute Myocardial Infarction

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Clinical Long-Term Outcome After Implantation of Titanium Nitride-Oxide Coated Stents Compared With Paclitaxel- Or Sirolimus-Eluting Stents: Propensity-Score Matched Analysis

EuroIntervention
MedicineCardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy